Funds holding Passage Bio Inc
ISIN US7027122099 · United States
- Fund holders
- 13
- Of which ETFs
- 2 11 other funds
- Value held
- 1.1M $
- Share of capital
- 4.4 % of 3.2M shares on Feb 26, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 78,764 | 618.3K $ | 2.46 % | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 35,200 | 276.3K $ | 0.00 % | 1.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 7,946 | 72.5K $ | 0.00 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 6,427 | 58.6K $ | 0.20 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 4,184 | 38.2K $ | 0.13 % | as of Feb 28, 2026 ↗ | |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 2,708 | 21.3K $ | 0.00 % | 0.08 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 1,544 | 7.9K $ | 0.05 % | as of Apr 30, 2026 ↗ | |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 1,263 | 6.5K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 1,069 | 5.5K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 792 | 4K $ | 0.02 % | as of Apr 30, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 623 | 5.7K $ | 0.02 % | as of Feb 28, 2026 ↗ | |
| Diversified Equity Master Portfolio Master Investment Portfolio | 504 | 4K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 293 | 1.5K $ | 0.01 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| TIFF MULTI-ASSET FUND TIFF Investment Program | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 13 | +2 | 141,317 | +2.3 % |
| 2026Q1 | 11 | +3 | 138,169 | -3.2 % |
| 2025Q4 | 8 | 142,720 |
Institutional managers
30 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| Lynx1 Capital Management LP | 623,704 | 4.9M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 305,000 | 2.4M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 133,612 | 1M $ | as of Mar 31, 2026 |
| Eversept Partners, LP | 131,581 | 1M $ | as of Mar 31, 2026 |
| Yiheng Capital Management, L.P. | 86,097 | 675.9K $ | as of Mar 31, 2026 |
| Erste Asset Management GmbH | 85,262 | 526.9K $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 68,124 | 534.8K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 41,380 | 324.9K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 28,595 | 224.5K $ | as of Mar 31, 2026 |
| UBS Group AG | 27,501 | 215.9K $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 24,196 | 189 $ | as of Mar 31, 2026 |
| Verdad Advisers, LP | 22,128 | 173.7K $ | as of Mar 31, 2026 |
| DIADEMA PARTNERS LP | 19,530 | 153.3K $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,871 | 148.1K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 12,627 | 99.1K $ | as of Mar 31, 2026 |
| Fiduciary Trust Co | 10,750 | 84.4K $ | as of Mar 31, 2026 |
| Persistent Asset Partners Ltd | 4,955 | 38.9K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,650 | 20.8K $ | as of Mar 31, 2026 |
| Rockefeller Capital Management L.P. | 800 | 6.3K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 502 | 3.9K $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 212 | 1.7K $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 124 | 973 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 115 | 903 $ | as of Mar 31, 2026 |
| Parallel Advisors, LLC | 16 | 126 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 15 | 117 $ | as of Mar 31, 2026 |
Declared shareholders of Passage Bio Inc
1 beneficial ownership filing. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Baselake Partners, LP and 2 others | 7.30 % | 235,058 | as of Jun 18, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Passage Bio Inc". https://titelia.com/en/stocks/passage-bio-inc-US7027122099